Baseline characteristic | Male (n = 916) | Female (n = 1,101) | Total (n = 2,017) | |||
---|---|---|---|---|---|---|
r | P-value | r | P-value | r | P-value | |
Sexa | - | Â | - | Â | 0.071 | 0.002 |
Age | –0.268 | < 0.001 | –0.146 | < 0.001 | –0.199 | < 0.001 |
Body mass index | 0.035 | 0.289 | 0.259 | < 0.001 | 0.164 | < 0.001 |
Smoking statusb | 0.058 | 0.078 | 0.167 | < 0.001 | 0.031 | 0.158 |
Drinking statusc | 0.222 | < 0.001 | 0.145 | < 0.001 | 0.101 | < 0.001 |
Cardiovascular disease | –0.017 | 0.610 | 0.003 | 0.908 | –0.010 | 0.644 |
Systolic blood pressure | –0.033 | 0.314 | –0.051 | 0.090 | –0.039 | 0.076 |
Diastolic blood pressure | 0.128 | < 0.001 | 0.006 | 0.834 | 0.052 | 0.018 |
Antihypertensive medicationd | –0.083 | 0.012 | 0.076 | 0.012 | 0.005 | 0.811 |
Triglycerides | 0.097 | 0.003 | 0.106 | < 0.001 | 0.099 | < 0.001 |
High-density lipoprotein cholesterol | 0.038 | 0.250 | –0.014 | 0.654 | 0.020 | 0.380 |
Low-density lipoprotein cholesterol | –0.002 | 0.959 | 0.051 | 0.094 | 0.043 | 0.056 |
Antilipidemic medicationd | –0.065 | 0.051 | –0.006 | 0.832 | –0.020 | 0.363 |
Blood glucose | –0.069 | 0.038 | 0.063 | 0.037 | –0.008 | 0.721 |
Antidiabetic medicationd | –0.081 | 0.015 | 0.034 | 0.256 | –0.033 | 0.135 |
Estimated glomerular filtration rate | 0.501 | < 0.001 | 0.419 | < 0.001 | 0.456 | < 0.001 |
Serum uric acid lowering medicationd | 0.137 | < 0.001 | 0.073 | 0.015 | 0.087 | < 0.001 |